Argenx
ARGX
#525
Rank
ยฃ30.83 B
Marketcap
ยฃ515.69
Share price
3.88%
Change (1 day)
58.78%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -ยฃ3.36

According to Argenx 's latest financial reports the company's current EPS (TTM) is -ยฃ3.32. In 2022 the company made an earnings per share (EPS) of -ยฃ10.48.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ3.36-67.92%
2022-ยฃ10.48